Evotec company profile
Company profile
Evotec has 4,379 employees and is headquartered in Hamburg, Germany.
With revenue of EUR 788.4 million in the fiscal year ended December 2025, down 1.1% from the previous year, and a net loss of EUR 103.5 million, Evotec SE employed 4,379 people. The company is headquartered in Hamburg, Germany, was founded in 1993, and changed its name from Evotec AG in April 2019.
Evotec SE focuses on drug discovery and development across oncology, autoimmune and inflammatory disorders, diabetes, heart failure, kidney and liver diseases, rare diseases, and central nervous system and cardiometabolic conditions. Its activity runs through two segments, Shared R&D and Just Evotec Biologics. Its clients range from drugmakers and biotech firms to universities, patient organisations and venture investors. Its markets include the US, Germany, France, Britain, Switzerland and other countries, and it works with academic partners such as the University of Oxford and Johns Hopkins University, as well as with Almirall on severe skin diseases.
Company facts
- Sector
- Industrials
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Germany
- Headquarters
- Essener Bogen 7, 22419, Hamburg
- Employees
- 4,379
- Chief executive
- Christian Wojczewski
- Founded
- 1993
- Fiscal year
- January - December
- Listing
- EVT · Xetra
- Currency
- EUR
- ISIN
- DE0005664809
- Website
- evotec.com
Evotec and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| EvotecEVT | Germany | $489.39M | 4,379 | -18.0% | — |
| PharmaNutraPHN | Italy | $917.61M | 146 | 22.0% | 36.7 |
| Faes FarmaFAE | Spain | $1.65B | 2,677 | 13.0% | 17.9 |
| FagronFAGR | Belgium | $1.97B | 4,880 | 14.3% | 19.5 |
| AlmirallALM | Spain | $2.45B | 2,108 | 9.6% | 30.2 |
| Siegfried HoldingSFZN | Switzerland | $3.4B | 4,454 | 16.7% | 16.7 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
